Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 139

1.

Vascular angiotensin II type 2 receptor attenuates atherosclerosis via a kinin/NO-dependent mechanism.

Takata H, Yamada H, Kawahito H, Kishida S, Irie D, Kato T, Wakana N, Miyagawa S, Fukui K, Matsubara H.

J Renin Angiotensin Aldosterone Syst. 2015 Jun;16(2):311-20. doi: 10.1177/1470320313491794. Epub 2013 Jun 4.

PMID:
23736171
2.

Deletion of angiotensin II type 2 receptor exaggerated atherosclerosis in apolipoprotein E-null mice.

Iwai M, Chen R, Li Z, Shiuchi T, Suzuki J, Ide A, Tsuda M, Okumura M, Min LJ, Mogi M, Horiuchi M.

Circulation. 2005 Sep 13;112(11):1636-43. Epub 2005 Sep 6.

3.

Angiotensin II type 2 receptor overexpression activates the vascular kinin system and causes vasodilation.

Tsutsumi Y, Matsubara H, Masaki H, Kurihara H, Murasawa S, Takai S, Miyazaki M, Nozawa Y, Ozono R, Nakagawa K, Miwa T, Kawada N, Mori Y, Shibasaki Y, Tanaka Y, Fujiyama S, Koyama Y, Fujiyama A, Takahashi H, Iwasaka T.

J Clin Invest. 1999 Oct;104(7):925-35.

4.

AT2 receptor stimulation increases aortic cyclic GMP in SHRSP by a kinin-dependent mechanism.

Gohlke P, Pees C, Unger T.

Hypertension. 1998 Jan;31(1 Pt 2):349-55.

5.

Evidence that nitric oxide inhibits vascular inflammation and superoxide production via a p47phox-dependent mechanism in mice.

Harrison CB, Drummond GR, Sobey CG, Selemidis S.

Clin Exp Pharmacol Physiol. 2010 Apr;37(4):429-34. doi: 10.1111/j.1440-1681.2009.05317.x. Epub 2009 Oct 16.

PMID:
19843095
6.

Cardiac angiotensin II type 2 receptor activates the kinin/NO system and inhibits fibrosis.

Kurisu S, Ozono R, Oshima T, Kambe M, Ishida T, Sugino H, Matsuura H, Chayama K, Teranishi Y, Iba O, Amano K, Matsubara H.

Hypertension. 2003 Jan;41(1):99-107.

7.

Bone marrow angiotensin AT2 receptor deficiency aggravates atherosclerosis development by eliminating macrophage liver X receptor-mediated anti-atherogenic actions.

Kato T, Kawahito H, Kishida S, Irie D, Wakana N, Kikai M, Takata H, Ogata T, Ueyama T, Matoba S, Yamada H.

J Renin Angiotensin Aldosterone Syst. 2015 Dec;16(4):936-46. doi: 10.1177/1470320314561138. Epub 2014 Dec 8.

PMID:
25487979
8.

Stimulation of the AT2 receptor reduced atherogenesis in ApoE(-/-)/AT1A(-/-) double knock out mice.

Tiyerili V, Mueller CF, Becher UM, Czech T, van Eickels M, Daiber A, Nickenig G, Wassmann S.

J Mol Cell Cardiol. 2012 Mar;52(3):630-7. doi: 10.1016/j.yjmcc.2011.12.007. Epub 2011 Dec 22.

PMID:
22230040
9.

Angiotensin II, type 2 receptor is not involved in the angiotensin II-mediated pro-atherogenic process in ApoE-/- mice.

Johansson ME, Wickman A, Fitzgerald SM, Gan LM, Bergström G.

J Hypertens. 2005 Aug;23(8):1541-9.

PMID:
16003181
10.

Chronic angiotensin IV treatment reverses endothelial dysfunction in ApoE-deficient mice.

Vinh A, Widdop RE, Drummond GR, Gaspari TA.

Cardiovasc Res. 2008 Jan;77(1):178-87. Epub 2007 Sep 19.

PMID:
18006471
11.

Vasoprotective and atheroprotective effects of angiotensin (1-7) in apolipoprotein E-deficient mice.

Tesanovic S, Vinh A, Gaspari TA, Casley D, Widdop RE.

Arterioscler Thromb Vasc Biol. 2010 Aug;30(8):1606-13. doi: 10.1161/ATVBAHA.110.204453. Epub 2010 May 6.

12.

Role of bradykinin, nitric oxide, and angiotensin II type 2 receptor in imidapril-induced angiogenesis.

Li P, Kondo T, Numaguchi Y, Kobayashi K, Aoki M, Inoue N, Okumura K, Murohara T.

Hypertension. 2008 Feb;51(2):252-8. Epub 2007 Dec 17.

13.

Endothelial-specific Nox2 overexpression increases vascular superoxide and macrophage recruitment in ApoE⁻/⁻ mice.

Douglas G, Bendall JK, Crabtree MJ, Tatham AL, Carter EE, Hale AB, Channon KM.

Cardiovasc Res. 2012 Apr 1;94(1):20-9. doi: 10.1093/cvr/cvs026. Epub 2012 Jan 27.

14.

Resistance to oxidative stress by chronic infusion of angiotensin II in mouse kidney is not mediated by the AT2 receptor.

Wesseling S, Ishola DA Jr, Joles JA, Bluyssen HA, Koomans HA, Braam B.

Am J Physiol Renal Physiol. 2005 Jun;288(6):F1191-200. Epub 2005 Feb 22.

15.

Angiotensin II modulates renal sympathetic neurotransmission through nitric oxide in AT2 receptor knockout mice.

Stegbauer J, Vonend O, Habbel S, Quack I, Sellin L, Gross V, Rump LC.

J Hypertens. 2005 Sep;23(9):1691-8.

PMID:
16093914
16.

Cardiac-specific overexpression of angiotensin II AT2 receptor causes attenuated response to AT1 receptor-mediated pressor and chronotropic effects.

Masaki H, Kurihara T, Yamaki A, Inomata N, Nozawa Y, Mori Y, Murasawa S, Kizima K, Maruyama K, Horiuchi M, Dzau VJ, Takahashi H, Iwasaka T, Inada M, Matsubara H.

J Clin Invest. 1998 Feb 1;101(3):527-35.

17.

IGF-1 reduces inflammatory responses, suppresses oxidative stress, and decreases atherosclerosis progression in ApoE-deficient mice.

Sukhanov S, Higashi Y, Shai SY, Vaughn C, Mohler J, Li Y, Song YH, Titterington J, Delafontaine P.

Arterioscler Thromb Vasc Biol. 2007 Dec;27(12):2684-90. Epub 2007 Oct 4.

18.

Mitochondria-targeted esculetin alleviates mitochondrial dysfunction by AMPK-mediated nitric oxide and SIRT3 regulation in endothelial cells: potential implications in atherosclerosis.

Karnewar S, Vasamsetti SB, Gopoju R, Kanugula AK, Ganji SK, Prabhakar S, Rangaraj N, Tupperwar N, Kumar JM, Kotamraju S.

Sci Rep. 2016 Apr 11;6:24108. doi: 10.1038/srep24108.

19.

Augmented superoxide production by Nox2-containing NADPH oxidase causes cerebral artery dysfunction during hypercholesterolemia.

Miller AA, De Silva TM, Judkins CP, Diep H, Drummond GR, Sobey CG.

Stroke. 2010 Apr;41(4):784-9. doi: 10.1161/STROKEAHA.109.575365. Epub 2010 Feb 18.

20.

Essential role of angiotensin II type 1a receptors in the host vascular wall, but not the bone marrow, in the pathogenesis of angiotensin II-induced atherosclerosis.

Koga J, Egashira K, Matoba T, Kubo M, Ihara Y, Iwai M, Horiuchi M, Sunagawa K.

Hypertens Res. 2008 Sep;31(9):1791-800. doi: 10.1291/hypres.31.1791.

PMID:
18971558

Supplemental Content

Support Center